NUDT16 and liver cancer: A (deoxy)insoine diphosphatase, NUDT16 (spearman = − 0.324, p < 0.005) was identified for the MSL, which shows that this protein has a biomarker-related role in RTK inhibitor treatment on liver cancer cell lines.